Literature DB >> 28751523

CCL3 is a key mediator for the leukemogenic effect of Ptpn11-activating mutations in the stem-cell microenvironment.

Lei Dong1, Hong Zheng1, Cheng-Kui Qu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28751523      PMCID： PMC5609337          DOI： 10.1182/blood-2017-06-791103

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

Review 1.  The role of Shp2 (PTPN11) in cancer.

Authors:  M Golam Mohi; Benjamin G Neel
Journal:  Curr Opin Genet Dev       Date:  2007-01-16       Impact factor: 5.578

2.  Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.

Authors:  M Golam Mohi; Ifor R Williams; Charles R Dearolf; Gordon Chan; Jeffery L Kutok; Sarah Cohen; Kelly Morgan; Christina Boulton; Hirokazu Shigematsu; Heike Keilhack; Koichi Akashi; D Gary Gilliland; Benjamin G Neel
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

3.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.

Authors:  Simón Méndez-Ferrer; Tatyana V Michurina; Francesca Ferraro; Amin R Mazloom; Ben D Macarthur; Sergio A Lira; David T Scadden; Avi Ma'ayan; Grigori N Enikolopov; Paul S Frenette
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

4.  Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.

Authors:  Lei Dong; Wen-Mei Yu; Hong Zheng; Mignon L Loh; Silvia T Bunting; Melinda Pauly; Gang Huang; Muxiang Zhou; Hal E Broxmeyer; David T Scadden; Cheng-Kui Qu
Journal:  Nature       Date:  2016-10-26       Impact factor: 49.962

5.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

6.  Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.

Authors:  Gordon Chan; Demetrios Kalaitzidis; Tatiana Usenko; Jeffery L Kutok; Wentian Yang; M Golam Mohi; Benjamin G Neel
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

7.  Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer.

Authors:  Malcolm Logan; James F Martin; Andras Nagy; Corrinne Lobe; Eric N Olson; Clifford J Tabin
Journal:  Genesis       Date:  2002-06       Impact factor: 2.487

8.  Requirement of MIP-1 alpha for an inflammatory response to viral infection.

Authors:  D N Cook; M A Beck; T M Coffman; S L Kirby; J F Sheridan; I B Pragnell; O Smithies
Journal:  Science       Date:  1995-09-15       Impact factor: 47.728

Review 9.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

10.  Arteriolar niches maintain haematopoietic stem cell quiescence.

Authors:  Yuya Kunisaki; Ingmar Bruns; Christoph Scheiermann; Jalal Ahmed; Sandra Pinho; Dachuan Zhang; Toshihide Mizoguchi; Qiaozhi Wei; Daniel Lucas; Keisuke Ito; Jessica C Mar; Aviv Bergman; Paul S Frenette
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962
View more
  2 in total

1.  SHP2 inhibition enhances the anticancer effect of Osimertinib in EGFR T790M mutant lung adenocarcinoma by blocking CXCL8 loop mediated stemness.

Authors:  Leiming Xia; Fan Yang; Xiao Wu; Suzhi Li; Chen Kan; Hong Zheng; Siying Wang
Journal:  Cancer Cell Int       Date:  2021-07-03       Impact factor: 5.722

2.  The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers.

Authors:  Rhonda J Staversky; Daniel K Byun; Mary A Georger; Brandon J Zaffuto; Alexandra Goodman; Michael W Becker; Laura M Calvi; Benjamin J Frisch
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.